Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 270

1.

Cyclooxygenase-3 (COX-3): filling in the gaps toward a COX continuum?

Warner TD, Mitchell JA.

Proc Natl Acad Sci U S A. 2002 Oct 15;99(21):13371-3. Epub 2002 Oct 8. Review. No abstract available.

2.

The discovery and function of COX-2.

Needleman P, Isakson PC.

J Rheumatol Suppl. 1997 Jul;49:6-8. Review. No abstract available.

PMID:
9249644
3.

COX-2 inhibitors--is there cause for concern?

Seibert K, Lefkowith J, Tripp C, Isakson P, Needleman P.

Nat Med. 1999 Jun;5(6):621-2. No abstract available.

PMID:
10371498
4.

Prostaglandin endoperoxide H synthases-1 and -2.

Smith WL, Dewitt DL.

Adv Immunol. 1996;62:167-215. Review. No abstract available.

PMID:
8781269
5.

Cox-2-selective inhibitors: the new super aspirins.

DeWitt DL.

Mol Pharmacol. 1999 Apr;55(4):625-31. Review. No abstract available.

6.

Are COX-2 inhibitors as effective as conventional NSAIDs in acute pain states?

Bannwarth B.

Arch Intern Med. 2001 Jan 8;161(1):127-8. No abstract available.

PMID:
11146712
7.

[New NSAIDS: COX-1, COX-2, what about them?].

Peretz A.

Rev Med Brux. 1998 Sep;19(4):A399-402. Review. French.

PMID:
9805982
8.

COX-1 and COX-2 inhibition: current status and future perspective.

Greyn J, Lauwers MH, Vanlersberghe C, Camu F.

Acta Anaesthesiol Belg. 1998;49(3):175-83. Review. No abstract available.

PMID:
9844704
9.

The future of NSAID therapy: selective COX-2 inhibitors.

Vane JR, Botting RM.

Int J Clin Pract. 2000 Jan-Feb;54(1):7-9. No abstract available. Erratum in: Int J Clin Pract 2000 Mar;54(2):73.

PMID:
10750251
10.

[COX-1 and COX-2: functions and pharmacological effects].

Hinz B, Brune K.

Pharm Unserer Zeit. 1999 Jan;28(1):21-9. Review. German. No abstract available.

PMID:
10078026
11.

Cyclooxygenase-2 inhibitors in tumorigenesis (Part II).

Taketo MM.

J Natl Cancer Inst. 1998 Nov 4;90(21):1609-20. Review.

PMID:
9811310
12.

4,5-Diaryloxazole inhibitors of cyclooxygenase-2 (COX-2).

Talley JJ, Bertenshaw SR, Brown DL, Carter JS, Graneto MJ, Koboldt CM, Masferrer JL, Norman BH, Rogier DJ Jr, Zwwifel BS, Seibert K.

Med Res Rev. 1999 May;19(3):199-208. Review.

PMID:
10232649
13.

2-Pyridinyl-3-(4-methylsulfonyl)phenylpyridines: selective and orally active cyclooxygenase-2 inhibitors.

Friesen RW, Brideau C, Chan CC, Charleson S, DeschĂȘnes D, DubĂ© D, Ethier D, Fortin R, Gauthier JY, Girard Y, Gordon R, Greig GM, Riendeau D, Savoie C, Wang Z, Wong E, Visco D, Xu LJ, Young RN.

Bioorg Med Chem Lett. 1998 Oct 6;8(19):2777-82.

PMID:
9873621
14.

[In vivo selectivity of nonsteroidal anti-inflammatory drugs on COX-1-COX-2 and gastrointestinal ulcers, in rats].

Laudanno OM, Cesolari JA, Esnarriaga J, Flaherty P, Vada J, Guastalli G, San Miguel P, Bedini OA.

Acta Gastroenterol Latinoam. 1998;28(3):249-55. Spanish.

PMID:
9773153
15.

[Biological functions of cyclooxygenase 2: control of its expression and activity].

Jacquemin C.

J Soc Biol. 2000;194(3-4):189-93. Review. French.

PMID:
11324321
16.

COX-2 inhibitors: a review.

Houston AM, Teach SJ.

Pediatr Emerg Care. 2004 Jun;20(6):396-9; quiz 400-2. Review. No abstract available.

PMID:
15179150
17.
18.

Cyclooxygenase inhibition for postoperative analgesia.

McCrory CR, Lindahl SG.

Anesth Analg. 2002 Jul;95(1):169-76. Review. No abstract available.

PMID:
12088963
19.

New perspectives for nonsteroidal antiinflammatory therapy.

de Brum-Fernandes AJ.

J Rheumatol. 1997 Feb;24(2):246-8. Review. No abstract available.

PMID:
9034978
20.

[Cyclooxygenases in the spinal cord and the relationship with pain].

Li SQ, Li WB.

Sheng Li Ke Xue Jin Zhan. 2003 Oct;34(4):359-60. Review. Chinese. No abstract available.

PMID:
14992024

Supplemental Content

Support Center